Sign Out
Boostagen-2 is a combined tetanus toxoid, reduced diphtheria toxoid, reduced recombinant pertussis vaccine (Tdapgen). Boostagen-2 is a sterile, whitish, turbid and uniform suspension. This vaccine contains purified tetanus toxoid, diphtheria toxoid and purified Bordetella pertussis antigens (recombinant Pertussis Toxin and FHA).
The recombinant Pertussis Toxin (rPT) is a genetically-detoxified PT (PTgen) obtained by recombinant DNA technology. Boostagen-2 (Tdap vaccine) meets the World Health Organisation (WHO) requirements for the manufacture of diphtheria, tetanus, and acellular pertussis combined vaccines.
Each single dose (0.5 mL) contains: Tetanus Toxoid 7.5 Lf, Diphtheria Toxoid 2.0 Lf, Bordetella pertussis antigens: Recombinant Pertussis Toxin (rPT) 2 μg, Filamentous Haemagglutinin (FHA) 5 μg.
Excipients/Inactive Ingredients: aluminum hydroxide, sodium chloride, water for injection.
Formaldehyde and thiomersal may be present in trace amounts as manufacturing process residuals.
Continue with Google